Parallel Advisors’s Quince Therapeutics QNCX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $487 | Hold |
295
| – | – | ﹤0.01% | 3280 |
|
|
2025
Q1 | $392 | Hold |
295
| – | – | ﹤0.01% | 3262 |
|
|
2024
Q4 | $552 | Hold |
295
| – | – | ﹤0.01% | 3185 |
|
|
2024
Q3 | $229 | Hold |
295
| – | – | ﹤0.01% | 3275 |
|
|
2024
Q2 | $221 | Sell |
295
-16
| -5% | -$12 | ﹤0.01% | 3178 |
|
|
2024
Q1 | $330 | Sell |
311
-2,065
| -87% | -$2.19K | ﹤0.01% | 3100 |
|
|
2023
Q4 | $2.5K | Hold |
2,376
| – | – | ﹤0.01% | 2735 |
|
|
2023
Q3 | $2.66K | Hold |
2,376
| – | – | ﹤0.01% | 2727 |
|
|
2023
Q2 | $3.58K | Hold |
2,376
| – | – | ﹤0.01% | 2551 |
|
|
2023
Q1 | $3.71K | Sell |
2,376
-65
| -3% | -$101 | ﹤0.01% | 2527 |
|
|
2022
Q4 | $1.56K | Hold |
2,441
| – | – | ﹤0.01% | 2777 |
|
|
2022
Q3 | $3K | Hold |
2,441
| – | – | ﹤0.01% | 2499 |
|
|
2022
Q2 | $5K | Buy |
2,441
+891
| +57% | +$1.83K | ﹤0.01% | 2264 |
|
|
2022
Q1 | $10K | Sell |
1,550
-76
| -5% | -$490 | ﹤0.01% | 2022 |
|
|
2021
Q4 | $21K | Sell |
1,626
-514
| -24% | -$6.64K | ﹤0.01% | 1747 |
|
|
2021
Q3 | $196K | Buy |
2,140
+904
| +73% | +$82.8K | 0.01% | 717 |
|
|
2021
Q2 | $66K | Buy |
1,236
+289
| +31% | +$15.4K | ﹤0.01% | 1091 |
|
|
2021
Q1 | $34K | Hold |
947
| – | – | ﹤0.01% | 1335 |
|
|
2020
Q4 | $26K | Hold |
947
| – | – | ﹤0.01% | 1363 |
|
|
2020
Q3 | $47K | Hold |
947
| – | – | ﹤0.01% | 1073 |
|
|
2020
Q2 | $43K | Hold |
947
| – | – | ﹤0.01% | 1106 |
|
|
2020
Q1 | $43K | Buy |
+947
| New | +$43K | ﹤0.01% | 1000 |
|